Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1293012.RAmXZ4ppf0XsTNI_0iM60oTdpD-LrR5ziUPTLueVC-Chw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1293012.RAmXZ4ppf0XsTNI_0iM60oTdpD-LrR5ziUPTLueVC-Chw130_assertion type Assertion NP1293012.RAmXZ4ppf0XsTNI_0iM60oTdpD-LrR5ziUPTLueVC-Chw130_head.
- NP1293012.RAmXZ4ppf0XsTNI_0iM60oTdpD-LrR5ziUPTLueVC-Chw130_assertion description "[However, no research has examined the connections or functions of LECT2 and the novel DPP-4 inhibitor, gemigliptin, in NAFLD pathogenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1293012.RAmXZ4ppf0XsTNI_0iM60oTdpD-LrR5ziUPTLueVC-Chw130_provenance.
- NP1293012.RAmXZ4ppf0XsTNI_0iM60oTdpD-LrR5ziUPTLueVC-Chw130_assertion evidence source_evidence_literature NP1293012.RAmXZ4ppf0XsTNI_0iM60oTdpD-LrR5ziUPTLueVC-Chw130_provenance.
- NP1293012.RAmXZ4ppf0XsTNI_0iM60oTdpD-LrR5ziUPTLueVC-Chw130_assertion SIO_000772 26297911 NP1293012.RAmXZ4ppf0XsTNI_0iM60oTdpD-LrR5ziUPTLueVC-Chw130_provenance.
- NP1293012.RAmXZ4ppf0XsTNI_0iM60oTdpD-LrR5ziUPTLueVC-Chw130_assertion wasDerivedFrom befree-2016 NP1293012.RAmXZ4ppf0XsTNI_0iM60oTdpD-LrR5ziUPTLueVC-Chw130_provenance.
- NP1293012.RAmXZ4ppf0XsTNI_0iM60oTdpD-LrR5ziUPTLueVC-Chw130_assertion wasGeneratedBy ECO_0000203 NP1293012.RAmXZ4ppf0XsTNI_0iM60oTdpD-LrR5ziUPTLueVC-Chw130_provenance.